Monopar Therapeutics

+$0.04 (+0.63%) As of 7:30 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.

About MNPR

Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The firm engages in building a drug development pipeline through the licensing and acquisition of oncology therapeutics in late preclinical and clinical development stages.

CEO
Chandler Drew Robinson
Employees
10
Headquarters
Wilmette, Illinois
Founded
2014

MNPR Key Statistics

Market Cap
74.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
13.37K
High Today
$5.62
Low Today
$5.50
Open Price
$5.55
Volume
8.44K
52 Week High
$17.01
52 Week Low
$4.28

MNPR Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure